OMIX

About us

OMIX SCIENCE is an AI-driven medical company, leveraging large models to offer personalized health prediction and disease intervention. Our technology research and development follow the path of “BT+MT+IT+AI” (Biotechnology + Medical Technology + Information Technology + Artificial Intelligence), forming a cross-disciplinary innovative technology. Our R&D capabilities have global competitiveness, aligning with the strategic directions of next-generation information infrastructure and the biopharmaceutical industry. Additionally, our solutions empower the silver economy. OMIX collaborates with leading enterprises and industrial funds in upstream and downstream sectors, aiming to build a world-class innovative “artificial intelligence + early detection of major complex diseases + aging intervention technology” scientific innovation ecosystem and an advanced industrial cluster.

Integrated Platform for “Prevention, Screening, Diagnosis, and Treatment”

Bridges the upstream and downstream of the healthcare ecosystem

Precise Tracking

Using globally advanced algorithmic AI models, only 5ml blood sample is needed to detect cancer signals, effectuating early cancer detection and cancer type tracing.

Sensitivity：>98%

Specificity：>85%

Technical Advantages

High Safety

Non-invasive

Radiation-free

Strong Early Warning

Early Detection

Early Treatment

High Specificity

Traceable

Less Worry

High Convenience

More convenient

More efficient

High Sensitivity

No omissions

More reassurance

2025-02

喜报 | 医疗AI肿瘤诊断模型获国家卫健委双项荣誉！

喜讯点燃创新之炬！在国家卫健委主办的2024年第二届全国数字健康创新应用大赛——医学人工智能主题赛上，奥明星程凭借自主研发的两大硬核科技——“TuFEst-多种复杂疾病同步早筛平台”与“多模态多组学深度图神经网络模型GRONET”，从全国265个顶尖团队中突围而出，荣获两项医学人工智能主题赛优胜奖，是唯一同时获得两个奖

2024-12

女性恶性肿瘤之首——不容忽视的“粉红杀手”

乳房不仅是女性身体的一部分，更是美丽、温柔与力量的象征。它哺育了生命，承载了爱。然而，乳房也很脆弱，它可能会悄悄遭遇乳腺癌的挑战与侵害。乳腺癌也被称为“粉红杀手”，是全球发病率前二的癌种。2022年，我国有35.72万乳腺癌新发病例，7.5万乳腺癌死亡病例。

2024-11

警惕癌症头号杀手

肺癌是众多癌症中发病率和死亡率的双重“冠军”。2024年国家癌症中心发布的最新全国癌症报告的数据显示：2022年我国新发肺癌病例高达106.06万，占据总新发癌症病例的22%；2022年我国因肺癌死亡病例高达73.33万，占据总癌症死亡病例的28%。肺癌已然是威胁人类健康的头号杀手。